Michael Kramer

Michael Kramer

Michael Kramer is the Founder of Mott Capital Management. His unique investment philosophy centers on seeking investment opportunities that are influenced by everyday life activities, and by observing new trends and products that are popular or are trending towards popularity. Additionally, he devotes a significant part of his research to global macroeconomics and central bank policies impacting financial markets.

Kramer runs the Mott Capital Management actively managed long-only Thematic Growth Portfolio, which holds these stocks: AAPL, ACAD, ALKS, CELG, DEO, DIS, GOOGL, MA, MO, NFLX, NXPI, RTN, SWKS TSLA, UL, V, VOD and VZ.

Kramer began his career in high-risk trading environments, trading both US and international equities. His trading skills coupled with his comprehensive, financial analysis of public companies, have given him a unique perspective on investing, which stands out from analysts who simply look at top-line numbers. In addition to fundamental analysis, Kramer also incorporates technical and options market analysis into his research.

Kramer is a fundamental writer for Investopedia.com, analyzing stocks and market news that is helpful for everyday investors to make short and long-term investment decisions.

  1. Stocks

    iPhone 8 Component Suppliers: Who Wins? (SWKS, AVGO)

    The next iPhone is coming and expectation are ramping. Which component supplier is the most highly leveraged to the iPhone ...
  2. Stocks

    The Contrarian: How High Can AVGO and SWKS Fly? (AVGO, SWKS)

    MKM Partners has a $109 price target on SWKS and a $240 price target on AVGO. Are they really worth that much?
  3. Stocks

    Is Pandora Media Worth $3 billion (P)

    BMO Capital raised its price target on Pandora Media to $13, but the company continues to lose money.
  4. Stocks

    Algorithms Run NVIDIA Trading (NVDA)

    Are machines and algorithms driving NVDA shares to the upside?
  5. Stocks

    Broadcom Up on RBC's Positive Comments (AVGO)

    Shares are up nearly one percent after RBC reiterated the stock as a top pick and raised its price target to $230.
  6. Stocks

    Teva Pops in Early Trading (TEVA)

    Teva is up this morning, after Momenta Pharmaceuticals announced a delay of its generic version of Copaxone.
  7. Stocks

    Did Broadcom Just Break Out? (AVGO)

    Shares of Broadcom are rising today after positive comments from JP Morgan.
  8. Stocks

    Why Unilever Said No To Kraft's $50/shr Merger Offer (UL, KHC)

    When you look at the fundamentals, it's clear why Unilever said no to Kraft Heinz's $50/share offer.
  9. Stocks

    IMAX Shares Fall on Heavy Volume (IMAX)

    Sometimes no news is good news. That's not the case for IMAX.
  10. Stocks

    NVIDIA Shares Are Off Highs And Heading Lower (NVDA)

    Shares of the chip and multimedia software company are down nearly 11% since it reported its quarterly results last week. ...
  11. Stocks

    A Look at the Big Gains in Acadia Pharmaceuticals in 2017 (ACAD)

    Shares of ACAD are off to fast start in 2017, but there is more to the story than just M&A activity.
  12. Stocks

    B. Riley Positive on IMAX (IMAX)

    B. Riley is positive on IMAX shares ahead of results on February 23rd. Will EPS follow the strong consecutive revenue results?
  13. Stocks

    CBS Revenue Falls Flat in Fourth Quarter (CBS)

    With revenue stumbling, how long can CBS buy back shares to increase EPS value?
  14. Stocks

    Valuing Toshiba's Flash Memory Unit (MU)

    Toshiba may be looking to sell all—not some—of its flash memory chip business as it deals with fallout in its nuclear unit.
  15. Stocks

    Options Activity High Ahead of CBS Quarterly Earnings (CBS)

    Options trading is elevated ahead of quarterly results from CBS. Is it a bearish bet?